Effect of an α-Glucosidase Inhibitor Combined with Sulphonylurea Treatment on Glucose Metabolism in Patients with Non-Insulin-Dependent Diabetes Mellitus
Restricted accessResearch articleFirst published online July, 1995
Effect of an α-Glucosidase Inhibitor Combined with Sulphonylurea Treatment on Glucose Metabolism in Patients with Non-Insulin-Dependent Diabetes Mellitus
Ten patients with non-insulin-dependent diabetes mellitus who were being treated with a sulphonylureal compound but whose glucose metabolism needed further improvement were given a combination of their usual sulphonylurea treatment and an α-glucosidase inhibitor. Treatment with the α-glucosidase inhibitor (0.6 mg/day), in addition to glibenclamide (7.5 mg/day in two patients; 5.0 mg/day in four; 2.5 mg/day in one) or tolbutamide (500 mg/day in three patients) for 4 weeks, improved hyperglycaemia after meals from 237 – 247 mg/dl to 192 mg/dl, and reduced glycosylated haemoglobin levels from 8.5 – 8.6% to 7.9% without causing hypoglycaemia.
KosakaKHaguraRKuzuyaTInsulin responses in equivocal and definite diabetes, with special reference to subjects who had mild glucose intolerance but later developed definite diabetes. Diabetes1977; 26: 944–951.
2.
KosakaKIncrease in insulin response after treatment of overt maturity-onset diabetes is independent of the mode of treatment. Diabetologia1980; 18: 23–28.
3.
RiddleMCEfficacy of bedtime NPH insulin with daytime sulfonylurea for subpopulation of type II diabetic subjects. Diabetes Care1989; 12: 623–629.
4.
BabaSα-glucosidase inhibitor. Med Pract1993; 10: 189–194.
5.
OkadaSIchikiKTanokuchiSDetermination of a cut-off point between treatable and untreatable ranges of nephropathy estimated from the urinary albumin index (UAI) in non-insulin dependent diabetes mellitus (NIDDM). in Recent Trends of Diabetes Mellitus in East Asia (MiuraGZhishengC eds). Amsterdam, New York, Oxford: Elsevier Science Publishers, BV, 1990; pp 239–242.
6.
OkadaSTanokuchiSIchikiKSignificance of urinary albumin index in the urine collected arbitrarily in the morning. Acta Med Okayama1990; 46: 165–168.
7.
WHO Study Group on Diabetes Mellitus Report of the WHO Expert Committee on Diabetes mellitus. Report No. 727 WHO Technical Report Series. Geneva, 1985.
8.
OdakaHEffect of a disaccharidase inhibitor, AO-128, on post-prandial hyperglycemia on rats. J Jpn Soc Nutr Food Sci1992; 45: 27–31.
